journal article·2026-07

Tunable magnetic properties and enhanced T2 relaxivity in Sr-doped LaMnO3 nanoparticles for biomedical imaging

G. Vignesh, M. Ashokkumar, S. Murugan

Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Magnetic and transport properties of perovskites and related materials · Multiferroics and related materials · Magnetic Properties and Synthesis of Ferrites

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (54)

Show source-provided references
1. Magnetic nanomaterials as contrast agents for MRI10.3390/ma13112586 ↗
2. Recent advances in polymer-coated iron oxide nanoparticles as magnetic resonance imaging contrast agents10.1007/s11051-021-05156-x ↗
3. Diagnosis of metastatic breast tumor with an Iron-Based hydrogen-bonded organic framework via T 2 -weighted magnetic resonance imaging10.1021/acs.analchem.4c06942 ↗
4. MRI techniques to decrease imaging times in children10.1148/rg.2020190112 ↗
5. The burst enhancement of MRI using magnetic resonance tuning Based contrast agents10.1021/acs.analchem.5c02870 ↗
6. Magnetic nanoparticles as MRI contrast agents10.1007/s41061-020-00302-w ↗
7. A review on the optimal design of magnetic nanoparticle-Based T2 MRI contrast agents10.3390/magnetochemistry6010011 ↗
8. Hydrogen-bonded organic frameworks chelated manganese for precise magnetic resonance imaging diagnosis of cancers10.1021/acs.nanolett.3c02466 ↗
9. MRI contrast agents and retention in the brain: review of contemporary knowledge and recommendations to the future10.1186/s13244-024-01763-z ↗
10. A robust and highly precise alternative against the proliferation of intestinal carcinoma and human hepatocellular carcinoma cells Based on lanthanum strontium manganite nanoparticles10.3390/ma14174979 ↗
11. Research progress in rare earth-doped perovskite manganite oxide nanostructures10.1186/s11671-019-3243-0 ↗
12. Exploring the role of strontium-based nanoparticles in modulating bone regeneration and antimicrobial resistance: a public health perspective10.1039/D5RA00308C ↗
13. Transverse Relaxivity of nanoparticle contrast agents for MRI: different magnetic cores and coatings10.1109/TMAG.2018.2844253 ↗
14. Multimodal superparamagnetic nanoparticles with unusually enhanced specific absorption rate for synergetic Cancer therapeutics and magnetic resonance imaging10.1021/acsami.6b02616 ↗
15. Recent advancements in manganite perovskites and spinel ferrite-based magnetic nanoparticles for biomedical theranostic applications10.1088/1361-6528/ab3f17 ↗
16. Chitosan PVA and Acalypha indica-based nanoformulation for antimicrobial activity against Staphylococcus aureus10.1007/s00289-023-05094-9 ↗
17. Gadolinium complex and phosphorescent probe-modified NaDyF4 nanorods for T1- and T2-weighted MRI/CT/phosphorescence multimodality imaging10.1016/j.biomaterials.2013.09.088 ↗
18. Facile combustion synthesis of granular-like La1-xSrxMnO3 perovskites as electrode material for supercapacitor application10.1016/j.est.2024.113841 ↗
19. Magnetic properties and photocatalytic activity of La0.8Ba0.2Fe0.9Mn0.1O3−δ and LaFe0.9Mn0.1O3−δ10.1016/j.molcata.2012.12.013 ↗
20. Magnetic properties of La0.67Sr0.33MnO3 epitaxial thin films grown on SrTiO3 (001)10.1016/j.jmmm.2020.166812 ↗
21. Advancements in pr-doped LaSrMnO3 perovskite nanoparticles: a novel platform for self-regulated magnetic hyperthermia applications10.1016/j.inoche.2025.115880 ↗
22. Tailoring the thermal and magnetic properties of lanthanum strontium manganite nanoparticles via magnesium doping for enhanced hyperthermic treatment of tumors10.1016/j.matchemphys.2026.132046 ↗
23. Enhanced electrochemical performance of LaMnO3 nanoparticles by ca/Sr doping10.3390/coatings14010020 ↗
24. Nanostructured manganese dioxide with adjustable Mn3+/Mn4+ ratio for flexible high-energy quasi-solid supercapacitors10.1016/j.cej.2020.125342 ↗
25. Tailoring the composition of strontium doped LaMnO3 perovskite oxide to enhance the activation of peroxymonosulfate for catalytic degradation of antibiotic in aqueous media10.1016/j.rineng.2025.107531 ↗
26. Synthesis and characterization of magnesium doped titania for photocatalytic degradation of methyl red10.1590/1517-7076-rmat-2021-44880 ↗
27. Effect of calcination temperature on La0.7Sr0.3MnO3 nanoparticles synthesized with modified sol-gel route10.1016/j.phpro.2014.10.035 ↗
28. Optimal oxygen vacancy concentration for CO 2 reduction in LSFCr perovskite: a combined density functional theory and thermogravimetric analysis measurement study10.1021/acs.jpcc.0c07097 ↗
29. Structural, morphological, differential scanning calorimetric and thermogravimetric studies of ball milled Fe doped nanoscale La0.67Sr0.33MnO3 manganite10.1007/s11664-017-5994-7 ↗
30. Study of structural, magnetic and radio frequency heating aptitudes of pure and (Fe-III) doped manganite (La1-x SrxMnO3) and their incorporation with sodium poly-styrene sulfonate (PSS) for magnetic hyperthermia applications10.1016/j.physb.2020.412627 ↗
31. Effect of Sr-doping on structural and magnetic properties of La1−xSr x MnO 3 nanoparticles10.1142/S1793292022500898 ↗
32. Charge, orbital and spin ordering phenomena in the mixed valence manganite (NaMn3+3)(Mn3+2Mn4+2)O1210.1038/nmat1038 ↗
33. Magnetic properties of La 0.7 Sr 0.3 MnO 3 under the pressure and the transport property under the magnetic field10.1111/jace.17495 ↗
34. Architectured design of superparamagnetic Fe 3 O 4 nanoparticles for application as MRI contrast agents: mastering size and magnetism for enhanced relaxivity10.1039/C5TB00789E ↗
35. Structure–relaxivity relationships of magnetic nanoparticles for magnetic resonance imaging
36. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications10.1021/cr980440x ↗
37. Magnetic Iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications10.1021/cr900197g ↗
38. Surface impact on nanoparticle-based magnetic resonance imaging contrast agents10.7150/thno.23789 ↗
39. NMR and spin relaxation in systems with magnetic nanoparticles: effects of size and molecular motion10.1088/0953-8984/21/25/255301 ↗
40. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T 1 - and T 2 -weighted magnetic resonance imaging10.1088/0957-4484/22/24/245604 ↗
41. A novel one-pot synthesis of PVP-coated iron oxide nanoparticles as biocompatible contrast agents for enhanced T2-weighted MRI10.3390/jcs7030131 ↗
42. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil10.1016/0730-725X(95)00024-B ↗
43. Current developments of Iron oxide nanomaterials as MRI Theranostic agents for pancreatic Cancer10.3390/jnt6030022 ↗
44. Superparamagnetic Iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in Neurooncology and central nervous system inflammatory pathologies, a review10.1038/jcbfm.2009.192 ↗
45. A highly effective, nontoxic T 1 MR contrast agent Based on ultrasmall PEGylated Iron oxide nanoparticles10.1021/nl902715v ↗
46. Targeted cancer therapy through self-regulated magnetic hyperthermia using biocompatible zirconium-doped LSMO nanoparticles10.1016/j.ces.2025.122731 ↗
47. Optical, morphological and biological analysis of zinc oxide nanoparticles (ZnO NPs) using Papaver somniferum L10.1039/C9RA04424H ↗
48. Different hydroxyapatite magnetic nanoparticles for medical imaging: its effects on hemostatic, hemolytic activity and cellular cytotoxicity10.1016/j.colsurfb.2016.06.042 ↗
49. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on Hemolytic activity10.1021/ja910846q ↗
50. Exploring the impact of pH on the properties of citric acid-coated iron oxide nanoparticles as high-performance T2 contrast agent for MRI applications10.1016/j.rineng.2023.101206 ↗
51. Thermal plasma synthesized Mn3O4 nanoparticles as T1 and T2 MRI contrast agents10.1016/j.ceramint.2024.05.247 ↗
52. Magnetic nanoparticles based on CoFe alloy as T 2 MRI contrast agents
53. Preparation and analysis of Mn1-xZnxFe2O4 nanoparticles coated with chitosan for use as a heating agent and MRI contrast agent in biomedical applications10.1016/j.jmmm.2024.171891 ↗
54. Core-shell magnetic nanoparticles: harnessing synergistic effects for MRI and magnetic hyperthermia